493 related articles for article (PubMed ID: 26100991)
41. CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia.
Thomas X; Archimbaud E; Charrin C; Magaud JP; Fiere D
Leukemia; 1995 Feb; 9(2):249-53. PubMed ID: 7532767
[TBL] [Abstract][Full Text] [Related]
42. Flow cytometric immunophenotyping analysis of patterns of antigen expression in non-Hodgkin's B cell lymphoma in samples obtained from different anatomic sites.
Gervasi F; Lo Verso R; Giambanco C; Cardinale G; Tomaselli C; Pagnucco G
Ann N Y Acad Sci; 2004 Dec; 1028():457-62. PubMed ID: 15650271
[TBL] [Abstract][Full Text] [Related]
43. Aberrant expression of B203.13 antigen in acute lymphoid leukemia of B-cell origin.
Gobbi G; Mirandola P; Malinverno C; Sponzilli I; Carubbi C; Ricci F; Binazzi R; Basso G; Giuliani-Piccari G; Ramazzotti G; Pasquantonio G; Cocco L; Vitale M
Int J Oncol; 2008 Aug; 33(2):371-4. PubMed ID: 18636158
[TBL] [Abstract][Full Text] [Related]
44. No prognostic significance of immunophenotypic changes at the end of remission induction therapy in children with B-lineage acute lymphoblastic leukemia.
Dai Q; Liu X; Yang H; Guo S; Wang Y; Peng L; Ye L; Chen L; Lai C; Chen Q; Zhang G; Jiang Y
Leuk Res; 2018 May; 68():57-61. PubMed ID: 29544133
[TBL] [Abstract][Full Text] [Related]
45. Cross-lineage expression in 505 patients with acute lymphoblastic leukemia by multiparametric flow cytometry analysis.
Wang XB; Du W; Xia L; Zheng JE; Liu J; He YL; Sun ZM; Huang SA
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1419-23. PubMed ID: 20030918
[TBL] [Abstract][Full Text] [Related]
46. Flow cytometric analysis of de novo acute lymphoblastic leukemia in childhood: report from the Japanese Pediatric Leukemia/Lymphoma Study Group.
Iwamoto S; Deguchi T; Ohta H; Kiyokawa N; Tsurusawa M; Yamada T; Takase K; Fujimoto J; Hanada R; Hori H; Horibe K; Komada Y
Int J Hematol; 2011 Aug; 94(2):185-192. PubMed ID: 21800074
[TBL] [Abstract][Full Text] [Related]
47. Early recovery of circulating immature B cells in B-lymphoblastic leukemia patients after CD19 targeted CAR T cell therapy: A pitfall for minimal residual disease detection.
Xiao W; Salem D; McCoy CS; Lee D; Shah NN; Stetler-Stevenson M; Yuan CM
Cytometry B Clin Cytom; 2018 May; 94(3):434-443. PubMed ID: 28888074
[TBL] [Abstract][Full Text] [Related]
48. [Analysis of immunophenotype of B-lineage acute lymphoblastic leukemia cells by 4-color flow cytometry].
Wang H; Liu YR; Chen SS; Chang Y; Qin YZ; Li JL; Fu JY; Ruan GR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Apr; 11(2):137-41. PubMed ID: 12744734
[TBL] [Abstract][Full Text] [Related]
49. Quantitative immunocytofluorometry--new parameters for the definition of leukemia cells.
Babusíková O; Glasová M; Stasáková J; Kusenda J; Koníková E
Neoplasma; 1997; 44(6):348-55. PubMed ID: 9605006
[TBL] [Abstract][Full Text] [Related]
50. Standardizing minimal residual disease by flow cytometry for precursor B lineage acute lymphoblastic leukemia in a developing country.
Patkar N; Alex AA; B B; Ahmed R; Abraham A; George B; Vishwabandya A; Srivastava A; Mathews V
Cytometry B Clin Cytom; 2012 Jul; 82(4):252-8. PubMed ID: 22467604
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of new markers for minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia: CD73 and CD86 are the most relevant new markers to increase the efficacy of MRD 2016; 00B: 000-000.
Tembhare PR; Ghogale S; Ghatwai N; Badrinath Y; Kunder N; Patkar NV; Bibi AR; Chatterjee G; Arora B; Narula G; Banawali S; Deshpande N; Amare P; Gujral S; Subramanian PG
Cytometry B Clin Cytom; 2018 Jan; 94(1):100-111. PubMed ID: 27718302
[TBL] [Abstract][Full Text] [Related]
52. Paraffin section immunophenotyping of acute leukemias in bone marrow specimens.
Arber DA; Jenkins KA
Am J Clin Pathol; 1996 Oct; 106(4):462-8. PubMed ID: 8853033
[TBL] [Abstract][Full Text] [Related]
53. Increased regulatory T cells in acute lymphoblastic leukemia patients.
Idris SZ; Hassan N; Lee LJ; Md Noor S; Osman R; Abdul-Jalil M; Nordin AJ; Abdullah M
Hematology; 2015 Oct; 20(9):523-9. PubMed ID: 26119924
[TBL] [Abstract][Full Text] [Related]
54. Comparison between CD19 and CD20 expression patterns on acute leukemic cells.
Ning BT; Tang YM; Chen YH; Shen HQ; Qian BQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):943-7. PubMed ID: 16403255
[TBL] [Abstract][Full Text] [Related]
55. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings.
Khalidi HS; Brynes RK; Medeiros LJ; Chang KL; Slovak ML; Snyder DS; Arber DA
Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654
[TBL] [Abstract][Full Text] [Related]
56. [Analysis of Immunophenotypes in 329 Patients with B-ALL at Different Ages].
Zheng YH; Lin YF; Xu RY; Zhou YZ; Huang YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1225-30. PubMed ID: 26524013
[TBL] [Abstract][Full Text] [Related]
57. Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases.
Raponi S; De Propris MS; Intoppa S; Milani ML; Vitale A; Elia L; Perbellini O; Pizzolo G; Foá R; Guarini A
Leuk Lymphoma; 2011 Jun; 52(6):1098-107. PubMed ID: 21348573
[TBL] [Abstract][Full Text] [Related]
58. [Comparison of the immunophenotype of patients with B lineage acute lymphoblastic leukemia at diagnosis and relapse].
Liu YR; Chang Y; Fu JY; Cheng YF; Zhang LP; Li LD; Wang H; Liu GL; Chen SS; Huang XJ; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):335-8. PubMed ID: 16875586
[TBL] [Abstract][Full Text] [Related]
59. Prognostic impact of CD45 antigen expression in high-risk, childhood B-cell precursor acute lymphoblastic leukemia.
Nakamura A; Tsurusawa M; Kato A; Taga T; Hatae Y; Miyake M; Mimaya J; Onodera N; Watanabe A; Watanabe T; Kanegane H; Matsushita T; Iwai A; Hyakuna N; Gushi K; Kawakami T; Sekine I; Izichi O; Asami K; Kikuta A; Tanaka A; Fujimoto T;
Leuk Lymphoma; 2001 Jul; 42(3):393-8. PubMed ID: 11699404
[TBL] [Abstract][Full Text] [Related]
60. Aberrant T-cell antigen expression in B lymphoblastic leukaemia.
Hussein S; Gill KZ; Sireci AN; Colovai AI; Small T; Emmons FN; Murty VV; Bhagat G; Alobeid B
Br J Haematol; 2011 Nov; 155(4):449-56. PubMed ID: 21923643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
